New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System
Year: 2025
Type: article
Language: en
Topic: Amyloidosis: Diagnosis, Treatment, Outcomes
Authors and affiliations:
raw_author_name: Jahanzaib Khwaja
raw_affiliation_strings: National Amyloidosis Centre, Royal Free London, UCL, London, United Kingdom
University College London Hospitals, London, United Kingdom
University College London Hospitals, UK
National Amyloidosis Centre, Royal Free London, UCL, UK
raw_author_name: Amy A. Kirkwood
raw_affiliation_strings: CRUK and UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London, United Kingdom
CRUK and UCL Cancer Trials Centre, UCL Cancer Institute, UCL
raw_author_name: Paolo Milani
raw_affiliation_strings: Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Department of Molecular Medicine, University of Pavia, Pavia, Italy
raw_author_name: Binoy Yohannan
raw_affiliation_strings: Mayo Clinic, Rochester, MN
Mayo Clinic, Rochester, MN, United States
raw_author_name: Foteini Theodorakakou
raw_affiliation_strings: Alexandra General Hospital, National and Kapodistrian University of Athens, Athens, Greece
raw_author_name: Flores Weverling
raw_affiliation_strings: University Medical Center Utrecht, University Utrecht, Utrecht, the Netherlands
University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
raw_author_name: Valeria Di Simone
raw_affiliation_strings: Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Department of Molecular Medicine, University of Pavia, Pavia, Italy
Division of Cardiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
raw_author_name: Sriram Ravichandran
raw_affiliation_strings: National Amyloidosis Centre, Royal Free London, UCL, London, United Kingdom
University College London Hospitals, London, United Kingdom
University College London Hospitals, UK
National Amyloidosis Centre, Royal Free London, UCL, UK
raw_author_name: Shaji Kumar
raw_affiliation_strings: Mayo Clinic, Rochester, MN
Mayo Clinic, Rochester, MN, United States
raw_author_name: Ioannis Petropoulos
raw_affiliation_strings: Alexandra General Hospital, National and Kapodistrian University of Athens, Athens, Greece
raw_author_name: Roberta Mussinelli
raw_affiliation_strings: Department of Molecular Medicine, University of Pavia, Pavia, Italy
raw_author_name: Oliver Cohen
raw_affiliation_strings: National Amyloidosis Centre, Royal Free London, UCL, London, United Kingdom
National Amyloidosis Centre, Royal Free London, UCL, UK
raw_author_name: Marish I.F.J. Oerlemans
raw_affiliation_strings: University Medical Center Utrecht, University Utrecht, Utrecht, the Netherlands
University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
raw_author_name: Eli Muchtar
raw_affiliation_strings: Mayo Clinic, Rochester, MN
Mayo Clinic, Rochester, MN, United States
raw_author_name: Kimon Stamatelopoulos
raw_affiliation_strings: Alexandra General Hospital, National and Kapodistrian University of Athens, Athens, Greece
raw_author_name: Helen J. Lachmann
raw_affiliation_strings: National Amyloidosis Centre, Royal Free London, UCL, London, United Kingdom
National Amyloidosis Centre, Royal Free London, UCL, UK
raw_author_name: Julian D. Gillmore
raw_affiliation_strings: National Amyloidosis Centre, Royal Free London, UCL, London, United Kingdom
National Amyloidosis Centre, Royal Free London, UCL, UK
raw_author_name: Alexandros Briasoulis
raw_affiliation_strings: Alexandra General Hospital, National and Kapodistrian University of Athens, Athens, Greece
raw_author_name: Morie Gertz
raw_affiliation_strings: Mayo Clinic, Rochester, MN
Mayo Clinic, Rochester, MN, United States
raw_author_name: Carol Whelan
raw_affiliation_strings: National Amyloidosis Centre, Royal Free London, UCL, London, United Kingdom
National Amyloidosis Centre, Royal Free London, UCL, UK
raw_author_name: Lucia Venneri
raw_affiliation_strings: National Amyloidosis Centre, Royal Free London, UCL, London, United Kingdom
National Amyloidosis Centre, Royal Free London, UCL, UK
raw_author_name: Marianna Fontana
raw_affiliation_strings: National Amyloidosis Centre, Royal Free London, UCL, London, United Kingdom
National Amyloidosis Centre, Royal Free London, UCL, UK
raw_author_name: Shameem Mahmood
raw_affiliation_strings: National Amyloidosis Centre, Royal Free London, UCL, London, United Kingdom
University College London Hospitals, London, United Kingdom
University College London Hospitals, UK
National Amyloidosis Centre, Royal Free London, UCL, UK
raw_author_name: Rahel Schwotzer
raw_affiliation_strings: University Hospital Zurich, Zurich, Switzerland
raw_author_name: Monique C. Minnema
raw_affiliation_strings: University Medical Center Utrecht, University Utrecht, Utrecht, the Netherlands
University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands
raw_author_name: Angela Dispenzieri
raw_affiliation_strings: Mayo Clinic, Rochester, MN
Mayo Clinic, Rochester, MN, United States
raw_author_name: Giovanni Palladini
raw_affiliation_strings: Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Department of Molecular Medicine, University of Pavia, Pavia, Italy
raw_author_name: Efstathios Kastritis
raw_affiliation_strings: Alexandra General Hospital, National and Kapodistrian University of Athens, Athens, Greece
raw_author_name: Ashutosh Wechalekar
raw_affiliation_strings: National Amyloidosis Centre, Royal Free London, UCL, London, United Kingdom
University College London Hospitals, London, United Kingdom
National Amyloidosis Centre, Royal Free London, UCL, UK
University College London Hospitals, UK